Kynurenic Acid Offers Added Value in Predicting ECT Outcomes in Depression.

Dellink A, Belge JB, Sienaert P, Lambrichts S, Schrijvers D, Van Diermen L, Morrens M, Coppens V

Open source

DOI
10.1159/000552240
Published
2026 Jun 18
Container
Neuropsychobiology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000552240,
  title = {Kynurenic Acid Offers Added Value in Predicting ECT Outcomes in Depression.},
  author = {Dellink A and Belge JB and Sienaert P and Lambrichts S and Schrijvers D and Van Diermen L and Morrens M and Coppens V},
  year = {2026},
  journal = {Neuropsychobiology},
  doi = {10.1159/000552240},
  url = {https://doi.org/10.1159/000552240}
}

RIS

TY  - JOUR
TI  - Kynurenic Acid Offers Added Value in Predicting ECT Outcomes in Depression.
AU  - Dellink A
AU  - Belge JB
AU  - Sienaert P
AU  - Lambrichts S
AU  - Schrijvers D
AU  - Van Diermen L
AU  - Morrens M
AU  - Coppens V
PY  - 2026
JO  - Neuropsychobiology
DO  - 10.1159/000552240
UR  - https://doi.org/10.1159/000552240
ER  - 

APA

A, D., JB, B., P, S., S, L., D, S., L, V. D., M, M., & V, C. (2026). Kynurenic Acid Offers Added Value in Predicting ECT Outcomes in Depression.. Neuropsychobiology. https://doi.org/10.1159/000552240

Source records